Literature DB >> 10400741

Lymphocyte deficiencies increase susceptibility to friend virus-induced erythroleukemia in Fv-2 genetically resistant mice.

K J Hasenkrug1.   

Abstract

The study of genetic resistance to retroviral diseases provides insights into the mechanisms by which organisms overcome potentially lethal infections. Fv-2 resistance to Friend virus-induced erythroleukemia acts through nonimmunological mechanisms to prevent early virus spread, but it does not completely block infection. The current experiments were done to determine whether Fv-2 alone could provide resistance or whether immunological mechanisms were also required to bring infection under control. Fv-2-resistant mice that were CD4(+) T-cell deficient were able to restrict early virus replication and spread as well as normal Fv-2-resistant mice, but they could not maintain control and developed severe Friend virus-induced splenomegaly and erythroleukemia by 6 to 8 weeks postinfection. Mice deficient in CD8(+) T cells and, to a lesser extent, B cells were also susceptible to late Friend virus-induced disease. Thus, Fv-2 resistance does not independently prevent FV-induced erythroleukemia but works in concert with the immune system by limiting early infection long enough to allow virus-specific immunity time to develop and facilitate recovery.

Entities:  

Mesh:

Year:  1999        PMID: 10400741      PMCID: PMC112728     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

Review 1.  Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection.

Authors:  B Chesebro; M Miyazawa; W J Britt
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

2.  Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex.

Authors:  B Chesebro; K Wehrly
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

3.  Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles.

Authors:  D G Munroe; J W Peacock; S Benchimol
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

4.  Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor.

Authors:  J P Li; A D D'Andrea; H F Lodish; D Baltimore
Journal:  Nature       Date:  1990-02-22       Impact factor: 49.962

5.  Spi-1 oncogene activation in Rauscher and Friend murine virus-induced acute erythroleukemias.

Authors:  F Moreau-Gachelin; D Ray; N J de Both; M J van der Feltz; P Tambourin; A Tavitian
Journal:  Leukemia       Date:  1990-01       Impact factor: 11.528

6.  Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.

Authors:  M Zijlstra; M Bix; N E Simister; J M Loring; D H Raulet; R Jaenisch
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

7.  The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias.

Authors:  F Moreau-Gachelin; D Ray; M G Mattei; P Tambourin; A Tavitian
Journal:  Oncogene       Date:  1989-12       Impact factor: 9.867

8.  Rfv-1 and Rfv-2, two H-2-associated genes that influence recovery from Friend leukemia virus-induced splenomegaly.

Authors:  B Chesebro; K Wehrly
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

9.  Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody production.

Authors:  D Doig; B Chesebro
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

10.  The effect of histocompatibility-2 type on response to friend leukemia virus in mice.

Authors:  F Lilly
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  31 in total

1.  Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.

Authors:  Ronald J Messer; Ulf Dittmer; Karin E Peterson; Kim J Hasenkrug
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

2.  CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection.

Authors:  Gennadiy Zelinskyy; Shelly J Robertson; Simone Schimmer; Ronald J Messer; Kim J Hasenkrug; Ulf Dittmer
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  In vitro and in vivo analyses of regulatory T cell suppression of CD8+ T cells.

Authors:  Kim J Hasenkrug; Lara M Myers
Journal:  Methods Mol Biol       Date:  2011

4.  Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection.

Authors:  U Dittmer; K E Peterson; R Messer; I M Stromnes; B Race; K J Hasenkrug
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 5.  Tetherin/BST-2: Restriction Factor or Immunomodulator?

Authors:  Sam X Li; Bradley S Barrett; Kejun Guo; Mario L Santiago
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

6.  Ex vivo and in vivo biological effects of a truncated form of the receptor tyrosine kinase stk when activated by interaction with the friend spleen focus-forming virus envelope glycoprotein or by point mutation.

Authors:  Karen Rulli; Takashi Yugawa; Charlotte Hanson; Delores Thompson; Sandra Ruscetti; Kazuo Nishigaki
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Effects of type I interferons on Friend retrovirus infection.

Authors:  Nicole Gerlach; Simone Schimmer; Siegfried Weiss; Ulrich Kalinke; Ulf Dittmer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs.

Authors:  Zoltán Bánki; Wilfried Posch; Asim Ejaz; Verena Oberhauser; Suzanne Willey; Christoph Gassner; Heribert Stoiber; Ulf Dittmer; Manfred P Dierich; Kim J Hasenkrug; Doris Wilflingseder
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

9.  Race between retroviral spread and CD4+ T-cell response determines the outcome of acute Friend virus infection.

Authors:  Rebecca Pike; Andrew Filby; Mickaël J-Y Ploquin; Urszula Eksmond; Rute Marques; Inês Antunes; Kim Hasenkrug; George Kassiotis
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

10.  The level of friend retrovirus replication determines the cytolytic pathway of CD8+ T-cell-mediated pathogen control.

Authors:  Gennadiy Zelinskyy; Sandra Balkow; Simone Schimmer; Tanja Werner; Markus M Simon; Ulf Dittmer
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.